Shandong Weigao repurchases shares, boosting treasury holdings

Shandong Weigao Group Medical Polymer Company Limited disclosed a repurchase of 440,000 H shares on September 19, 2025, according to its Next Day Disclosure Return. These shares were repurchased on the Exchange at prices ranging from HK$5.73 to HK$5.88, with an aggregate price paid of HK$2,560,200. The repurchase resulted in an increase in treasury shares from 21,402,000 to 21,842,000, while issued shares excluding treasury shares decreased from 4,500,930,324 to 4,500,490,324.

The repurchase represents 0.0098% of the existing number of issued shares (excluding treasury shares) before the event. The total number of issued shares remains unchanged at 4,522,332,324. The company holds a mandate to repurchase 451,560,392 shares, granted on May 27, 2025.

To date, Shandong Weigao has repurchased 15,193,600 shares, representing 3.3647% of its issued shares (excluding treasury shares) as at the mandate date. A moratorium period for new share issues or treasury share transfers is in effect until October 19, 2025.